Authors: Wiseman, GA White, CA Sparks, RB Erwin, WD Podoloff, DA Lamonica, D Bartlett, NL Parker, JA Dunn, WL Spies, SM Belanger, R Witzig, TE Leigh, BR

Citation: Ga. Wiseman et al., Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, CR R ONC H, 39(1-2), 2001, pp. 181-194

Authors: Stabin, MG Siegel, JA Sparks, RB Eckerman, KF Breit, HB

Citation: Mg. Stabin et al., Contribution to red marrow absorbed dose from total body activity: A correction to the MIRD method, J NUCL MED, 42(3), 2001, pp. 492-498

Authors: Pivonka, DE Sparks, RB

Citation: De. Pivonka et Rb. Sparks, Implementation of Raman spectroscopy as an analytical tool throughout the synthesis of solid-phase scaffolds, APPL SPECTR, 54(11), 2000, pp. 1584-1590

Authors: Mozley, PD Stubbs, JB Dresel, SH Barraclough, ED Smith, T Patel, M Finkelman, C Sparks, RB Thakur, ML Mathur, A Alavi, A

Citation: Pd. Mozley et al., Radiation dosimetry of a Tc-99m-labeled IgM murine antibody to CD15 antigens on human granulocytes, J NUCL MED, 40(4), 1999, pp. 625-630